[New therapeutic approaches to peptic ulcer using mucosal protective agents]

Nihon Rinsho. 2002 Feb:60 Suppl 2:377-81.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Ulcer Agents / pharmacology
  • Anti-Ulcer Agents / therapeutic use*
  • Bicarbonates
  • Carnosine / analogs & derivatives*
  • Carnosine / pharmacology
  • Carnosine / therapeutic use
  • Chalcone / analogs & derivatives*
  • Chalcone / pharmacology
  • Chalcone / therapeutic use
  • Chalcones
  • Diterpenes / pharmacology
  • Diterpenes / therapeutic use
  • Enprostil / pharmacology
  • Enprostil / therapeutic use
  • Gastric Mucosa / blood supply
  • Gastric Mucosa / physiology
  • Helicobacter Infections / complications
  • Helicobacter Infections / drug therapy
  • Helicobacter pylori
  • Humans
  • Mucus / physiology
  • Organometallic Compounds / pharmacology
  • Organometallic Compounds / therapeutic use
  • Peptic Ulcer / drug therapy*
  • Peptic Ulcer / etiology
  • Peptic Ulcer / physiopathology
  • Piperidines / pharmacology
  • Piperidines / therapeutic use
  • Prostaglandins / physiology
  • Sucralfate / pharmacology
  • Sucralfate / therapeutic use

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Anti-Ulcer Agents
  • Bicarbonates
  • Chalcones
  • Diterpenes
  • Organometallic Compounds
  • Piperidines
  • Poraprezinc
  • Prostaglandins
  • sofalcone
  • Sucralfate
  • Chalcone
  • Carnosine
  • Enprostil
  • geranylgeranylacetone
  • troxipide